<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40">
 <mixed-citation publication-type="journal">
  <name>
   <surname>Lin</surname>
   <given-names>TI</given-names>
  </name>
  <name>
   <surname>Lenz</surname>
   <given-names>O</given-names>
  </name>
  <name>
   <surname>Fanning</surname>
   <given-names>G</given-names>
  </name>
  <name>
   <surname>Verbinnen</surname>
   <given-names>T</given-names>
  </name>
  <name>
   <surname>Delouvroy</surname>
   <given-names>F</given-names>
  </name>
  <name>
   <surname>Scholliers</surname>
   <given-names>A</given-names>
  </name>
  <name>
   <surname>Vermeiren</surname>
   <given-names>K</given-names>
  </name>
  <name>
   <surname>Rosenquist</surname>
   <given-names>A</given-names>
  </name>
  <name>
   <surname>Edlund</surname>
   <given-names>M</given-names>
  </name>
  <name>
   <surname>Samuelsson</surname>
   <given-names>B</given-names>
  </name>
  <article-title>In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2009</year>
  <volume>53</volume>
  <fpage>1377</fpage>
  <lpage>1385</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.01058-08</pub-id>
  <pub-id pub-id-type="pmid">19171797</pub-id>
 </mixed-citation>
</ref>
